Hospital-Acquired Infection Control Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Hospital-acquired infections (HAIs) are infections that patients get while receiving treatment for medical or surgical conditions. HAIs occur in all settings of care, including hospitals, surgical centers, ambulatory clinics, and long-term care facilities such as nursing homes and rehabilitation facilities.

The rapidly rising cases of HAIs and the increasing number of frequent hospital visits due to the rising prevalence of chronic diseases significantly contribute to the increasing demand for HAI control systems. Furthermore, the COVID- 19 crisis boosted the demand for advanced HAI control systems. Furthermore, increasing death rates due to HAIs are also responsible for the improvement in the infection prevention controls (IPCs)  in the hospitals. According to WHO, over 24% of patients affected by healthcare-associated sepsis and 52.3% of those patients treated in an intensive care unit die each year. Deaths are increased two to threefold when infections are resistant to antimicrobials. Furthermore, the increasing awareness about the general infections related to hospitals can also drive the market for HAIs controls.

Request to Download Sample of this Strategic Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=20588

According to UnivDatos Market Insights (UMI)’ research report “Global Hospital Acquired Infection Control Market Analysis, 2021”, The global hospital-acquired infection control (HAIC) Market is anticipated to grow with an elevated CAGR of around 4% over the forecast period (2021-2027). Hospital-Acquired Infections are the infections that occur in hospitals due to contaminated equipment, furniture, washrooms, or others. Diseases like sepsis, tuberculosis, and influenza are commonly spread from hospitals. 

Based on the product & services type, the market is segmented into protective barriers, sterilization, disinfectants, disinfectors, endoscope reprocessing products, and others. The protective barriers held for the majority of the market share in 2020. The increased market owing to the government restriction during the COVID-19 pandemic and to avoid the risk of the infection resulted in the tremendous growth for the protective barriers in the HAI control market. Furthermore, the increasing awareness regarding the prevention from HAIs such as pneumonia and influenza is responsible for the market of the segment.

For more informative information, please visit us – https://univdatos.com/get-a-free-sample-form-php/?product_id=20588

Based on end-users, the market is segmented into hospitals & ICUs, ambulatory surgical & diagnostic centers, and others. The hospitals & ICUs segment grabbed major market share in the HAI control market in 2020. This is mainly due to the rapidly increasing multiple drug-resistant pathogens, and rising medical visits of the elderly are increasing the concerns for healthcare facilities to minimize the probability of HAI infections on their premises contributing to the growth of the segment during the forecast period.

North America to Grab Lion’s Share, and witnessed Explicit Growth

For a better understanding of the market adoption of the Hospital-acquired infection control, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World.  North America constitutes a major share in the industry. The major factors such as favorable government initiatives, and increased investments in research and development to reduce risk from HAI coupled with the rapid increase in the geriatric population are propelling the growth of this market in the region. For instance, the number of Americans aged 60 and older increased by 34% from 55.7 million to 74.6 million between 2009 and 2019.

For more informative information, please visit us – https://univdatos.com/report/hospital-acquired-infection-control-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the HAIC Market include STERIS plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, MATACHANA GROUP, MMM Group, Belimed AG, Reckitt Benckiser. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Hospital Acquired Infection Control Market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for home care monitoring and diagnostics providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/hospital-acquired-infection-control-market/

Market Segmentation:

1. By Product & Service (Protective Barriers, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products, and Others)
2. By End-user (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, and Nursing Homes & Maternity Centers)
3. By Region (North America, Europe, Asia-Pacific, Rest of the World)
4. By Company (STERIS plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, MATACHANA GROUP, MMM Group, Belimed AG, Reckitt Benckiser.)

Key questions answered in the study:

1. What are the current and future trends of the home care monitoring and diagnostics industry?
2. How the industry has been evolving in terms of product & service and end-user?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the home care monitoring and diagnostics industry?
5. What is the customer orientation, purchase behavior, and expectations from the home care monitoring and diagnostics firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL HOSPITAL-ACQUIRED INFECTION CONTROL (HAIC) MARKET COVID-19 IMPACT

6 GLOBAL HOSPITAL-ACQUIRED INFECTION CONTROL (HAIC) MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT & SERVICES

8 MARKET INSIGHTS BY END-USERS

9 MARKET INSIGHTS BY REGION

10 HOSPITAL- ACQUIRED INFECTION CONTROL (HAIC) MARKET DYNAMICS

11 HOSPITAL- ACQUIRED INFECTION CONTROL (HAIC) MARKET OPPORTUNITIES

12 HOSPITAL- ACQUIRED INFECTION CONTROL (HAIC) MARKET TRENDS

13 LEGAL & REGULATORY FRAMEWORK

14 DEMAND AND SUPPLY SIDE ANALYSIS

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

• Kyphoplasty Market to Reach US$ 3.2 Billion by 2027 Globally | CAGR: 14.5% |
• Defibrillator Market to Reach US$ 15.5 Billion by 2027 Globally |CAGR: 5.3%|
• 3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |
• Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|